Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says. Watch here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVictrex Regulatory News (VCT)

Share Price Information for Victrex (VCT)

Share Price is delayed by 15 minutes
Get Live Data
604.00    -3.00 (-0.49%)
Bid:
605.00
Ask:
606.00
Spread: 1.00 (0.165%)
Market Cap: £526.23m
VCT Live PriceLast checked at - London Stock Exchange

Intraday Victrex Share Chart

Director/PDMR Shareholding

10 Feb 2023 14:12

RNS Number : 6220P
Victrex PLC
10 February 2023
 

10 February 2023

Victrex plc (the Company)

Grant of Options under the Victrex plc 2015 UK Sharesave Plan

Notification of transactions by directors/persons discharging managerial responsibilities

Victrex plc announces that it has launched two 2023 Save As You Earn Schemes (the "SAYE Scheme"). The SAYE Scheme is an all-employee scheme which gives the opportunity to eligible UK employees to acquire shares at a discount, over 3 or 5 years.

Eligible employees were invited to subscribe for options over the Company's ordinary shares of 1p each ("Shares"), with an exercise price of £13.936 per share representing a 20% discount to the closing mid-market price on 11 January 2023, the day before the invitation to participate was made. The exercise price was calculated in accordance with the rules of the SAYE. The options have a savings start date of 1 April 2023 and will normally be exercisable for 6 month period commencing 1 April 2026 for the 3 Year contract, and 1 April 2028 for the 5 Year contract.

A total of 463 employees elected to participate in the 2023 SAYE Scheme accordingly a total of 374,055 options were granted on 9 February 2023. In consideration of these options, the grantees will make monthly savings during the associated savings contract.

The following Persons Discharging Managerial Responsibility ("PDMRs") have chosen to participate in the 2023 SAYE Scheme:

Name

Position

No. of shares under options granted

Savings Contract Period

Jakob Sigurdsson

Executive Director

2,152

5 Years

Martin Court

Executive Director

645

3 Years

Ian Melling

Executive Director

1,291

3 Years

 

The FCA notification, made in accordance with the requirements of the EU Market Abuse Regulation is appended below and gives further details on the option grants for directors and PDMRs.

  

 

 

 

 

 

NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

1.  Jakob Sigurdsson

2.  Martin Court

3.  Ian Melling

2

Reason for the notification

a)

Position/status

Executive Director (PDMR)

b)

Initial notification/Amendment

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Victrex plc

b)

LEI

213800UYNPHAUNHPXL67

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

 

Identification code

Option over ordinary shares of 1p each

 

 

GB0009292243

b)

Nature of the transaction

Option granted under the Company's all-employee HMRC approved Save As You Earn scheme (Victrex plc 2015 UK Sharesave Plan) with an exercise price of £13.936.

c)

Price(s) and volume(s)

 

Price(s)

Volume(s)

1.

£13.936

2,152

2.

£13.936

645

3.

£13.936

1,291

 

d)

Aggregated information

- Aggregated volume

- Price

 

N/A

N/A

 

e)

Date of the transaction

9 February 2023

f)

Place of the transaction

Outside a trading venue

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHMZGMZDGMGFZM
Date   Source Headline
10th May 20231:34 pmRNSDirector/PDMR Shareholding
9th May 20237:00 amRNSVictrex plc - Interim Results 2023
28th Apr 20239:33 amRNSTotal Voting Rights
18th Apr 20232:00 pmRNSHolding(s) in Company
18th Apr 202310:50 amRNSDirector/PDMR Shareholding
4th Apr 20237:00 amRNSDirectorate Change
31st Mar 202310:52 amRNSTotal Voting Rights
20th Mar 20233:07 pmRNSHolding(s) in Company
20th Mar 202310:15 amRNSDirector/PDMR Shareholding
13th Mar 202310:14 amRNSAdditional Listing
28th Feb 20239:35 amRNSTotal Voting Rights
17th Feb 202310:06 amRNSDirector/PDMR Shareholding
14th Feb 202312:20 pmRNSDirector/PDMR Shareholding
10th Feb 20232:12 pmRNSDirector/PDMR Shareholding
10th Feb 202312:29 pmRNSResult of AGM
10th Feb 20237:00 amRNSAGM & Q1 Interim Management Statement
31st Jan 202310:43 amRNSTotal Voting Rights
17th Jan 20232:12 pmRNSDirector/PDMR Shareholding
12th Jan 20232:28 pmRNSCorrection - AGM Resolution Proposal
6th Jan 20232:58 pmRNSAnnual Report and Accounts
30th Dec 20229:00 amRNSTotal Voting Rights
22nd Dec 202211:30 amRNSDirector/PDMR Shareholding
19th Dec 202212:04 pmRNSDirector/PDMR Shareholding
19th Dec 202210:56 amRNSDirector/PDMR Shareholding
13th Dec 202211:16 amRNSDirector/PDMR Shareholding
6th Dec 20227:00 amRNSVictrex plc – Preliminary Results 2022
1st Dec 202211:49 amRNSBlock listing Interim Review
30th Nov 20229:27 amRNSTotal Voting Rights
29th Nov 20224:05 pmRNSHolding(s) in Company
17th Nov 20222:50 pmRNSDirector/PDMR Shareholding
17th Nov 20221:35 pmRNSAdditional Listing
31st Oct 202212:55 pmRNSTotal Voting Rights
18th Oct 202212:26 pmRNSDirector/PDMR Shareholding
30th Sep 202211:03 amRNSTotal Voting Rights
28th Sep 20229:44 amRNSHolding(s) in Company
20th Sep 20224:05 pmRNSDirector/PDMR Shareholding
31st Aug 20229:00 amRNSTotal Voting Rights
17th Aug 20222:31 pmRNSDirector/PDMR Shareholding
29th Jul 202210:01 amRNSTotal Voting Rights
19th Jul 20222:41 pmRNSDirector/PDMR Shareholding
7th Jul 20227:00 amRNSVictrex Q3 Interim Management Statement
30th Jun 202210:28 amRNSTotal Voting Rights
21st Jun 202212:41 pmRNSDirector/PDMR Shareholding
7th Jun 202211:45 amRNSBlock listing Interim Review
31st May 20229:59 amRNSTotal Voting Rights
27th May 20229:40 amRNSHolding(s) in Company
17th May 20223:58 pmRNSHolding(s) in Company
17th May 202212:19 pmRNSDirector/PDMR Shareholding
13th May 202211:02 amRNSDirector/PDMR Shareholding
9th May 20227:00 amRNSVictrex plc – Interim Results 2022

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.